Cargando…

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease

Patients with liver diseases acquire complex alterations in their hemostatic system that may lead to abnormalities in routine diagnostic test of hemostasis. Thrombocytopenia, prolongations in the prothrombin time and activated partial thromboplastin time, and decreased plasma fibrinogen are common i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lisman, Ton, Hernandez‐Gea, Virginia, Magnusson, Maria, Roberts, Lara, Stanworth, Simon, Thachil, Jecko, Tripodi, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Isth Ssc Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252070/ https://www.ncbi.nlm.nih.gov/pubmed/33792172 http://dx.doi.org/10.1111/jth.15239

Ejemplares similares

Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH
por: Mutch, Nicola J., et al.
Publicado: (2022)

International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis
por: van Ommen, C. Heleen, et al.
Publicado: (2021)

Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis
por: Betensky, Marisol, et al.
Publicado: (2022)

GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis
por: Megy, Karyn, et al.
Publicado: (2021)

Is it possible to make a common reference standard for D‐dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis
por: Bevan, Sally, et al.
Publicado: (2021)

Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH
por: Konkle, Barbara, et al.
Publicado: (2020)

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
por: den Exter, Paul L., et al.
Publicado: (2022)

Minimum information to report about a flow cytometry experiment on extracellular vesicles: Communication from the ISTH SSC subcommittee on vascular biology
por: van der Pol, Edwin, et al.
Publicado: (2021)

Clinical management, ethics and informed consent related to multi‐gene panel‐based high throughput sequencing testing for platelet disorders: Communication from the SSC of the ISTH
por: Downes, Kate, et al.
Publicado: (2020)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
por: Ariens, Robert, et al.
Publicado: (2020)

ISTH 2017 Berlin revisited
por: Ruf, Wolfram
Publicado: (2017)

Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study
por: Werner, Maureen J. M., et al.
Publicado: (2020)

Hemostasis and tumor immunity
por: Cantrell, Rachel, et al.
Publicado: (2022)

Differentiating biochemical from clinical heparin resistance in COVID-19
por: Lisman, Ton, et al.
Publicado: (2020)

Fibrin clot properties and thrombus composition in cirrhosis
por: Driever, Ellen G., et al.
Publicado: (2023)

Hemostatic phenotypes and genetic disorders
por: Ver Donck, Fabienne, et al.
Publicado: (2021)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Hemostatic defects in congenital disorders of glycosylation
por: Pascreau, Tiffany, et al.
Publicado: (2023)

Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH
por: Megy, Karyn, et al.
Publicado: (2019)

Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease
por: Lisman, Ton, et al.
Publicado: (2020)

Heparin – Messias or Verschlimmbesserung?
por: Swan, Dawn, et al.
Publicado: (2021)

Preanalytical conditions that affect coagulation testing, including hormonal status and therapy
por: BLOMBÄCK, M, et al.
Publicado: (2007)

Evaluation of hemostasis in patients with end-stage renal disease
por: Gäckler, Anja, et al.
Publicado: (2019)

Tranexamic Acid Is Not a Universal Hemostatic Agent
por: Schutgens, Roger E. G., et al.
Publicado: (2021)

Editorial: Introduction to the Presentations at the Factor XI and the Contact System SSC Session of the ISTH, Montpellier, France, May 27, 2016
por: Schmaier, Alvin H., et al.
Publicado: (2017)

ISTH Abstract
Publicado: (2022)

Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection
por: Nielsen, Nick S., et al.
Publicado: (2017)

Research and Practice in Thrombosis and Haemostasis – a new ISTH publishing platform for the global thrombosis and hemostasis community
por: Pabinger, Ingrid, et al.
Publicado: (2017)

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding
por: Abdoellakhan, Rahat A., et al.
Publicado: (2019)

Hemostasis, bleeding and thrombosis in liver disease
por: Flores, Brisas, et al.
Publicado: (2017)

Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
por: Arshad, Freeha, et al.
Publicado: (2014)

Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH
por: Geddings, J, et al.
Publicado: (2014)

Treatment of bleeding in patients with liver disease
por: Northup, Patrick G., et al.
Publicado: (2021)

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress
por: Kahn, Susan R., et al.
Publicado: (2023)

Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
por: Lisman, Ton, et al.
Publicado: (2017)

Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
por: Jain, Shilpa, et al.
Publicado: (2018)

Pathophysiology and management of bleeding and thrombosis in patients with liver disease
por: van den Boom, Bente P., et al.
Publicado: (2022)

Considerations for use of direct oral anticoagulants in arterial disease
por: Siegal, Deborah M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n93etp35n651c6bdl02jmpv3pg